Tonix Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNXP and other ETFs, options, and stocks.About TNXP
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800.
TNXP Key Statistics
Stock Snapshot
The current Tonix Pharmaceuticals(TNXP) stock price is $19.62, with a market capitalization of 231.05M. The stock trades at a price-to-earnings (P/E) ratio of -0.02.
On 2025-12-12, Tonix Pharmaceuticals(TNXP) stock moved within a range of $19.40 to $20.56. With shares now at $19.62, the stock is trading +1.1% above its intraday low and -4.6% below the session's peak.
Trading activity shows a volume of 196.16K, compared to an average daily volume of 606.06K.
Over the past 52 weeks, Tonix Pharmaceuticals(TNXP) stock has traded between a high of $130.00 and a low of $6.76.
Over the past 52 weeks, Tonix Pharmaceuticals(TNXP) stock has traded between a high of $130.00 and a low of $6.76.
TNXP News
TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...
Tonix Pharmaceuticals (TNXP) announced the appointment of Irina Ishak as General Counsel, effective December 8, 2025. Ishak will lead Tonix’s legal, corporate g...